se of Omalizumab will increase the pregnancy rate, proof of concept study, where women with asthma and infertility will be treated three times with weight and IgE balanced dosis at the sixth day of their period bleeding. - Use of Omalizumab will increase the pregnancy rate, proof of concept study, where women with asthma

Hvidovre Hospital. Dep of Respiratory Medicine0 个研究点目标入组 180 人开始时间: 2018年4月25日最近更新: 2024年4月15日

适应症

试验速览

暂无简介。

•* 18-40 years old
•Informed consent
•Diagnosis of asthma with or without allergy
•Infertility due to male factor infertility, tubal factor infertility or unexplained infertility.
•Referred to IVF treatment with or without ICSI
•Willingness to receive treatment with biologic drugs during menstruation period
•Controlled disease with an ACQ = 1.5
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 180
•F.1.3 Elderly (>=65 years) no
•F.1.3.1 Number of subjects for this age range

•Other respiratory diseases than asthma
•Other inflammatory disease or a disease that affects fertility.
•Allergy to the investigational drugs
•Respiratory infections requiring antibiotics or anti-viral treatment within 30 days
•TESA / TESE, Endometriosis
•Infertility due to other reasons than male factor, tubal factor or unexplained infertility

发起方

Hvidovre Hospital. Dep of Respiratory Medicine